REG-argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.Globe Newswire•06/08/2026•07:48 ET0 ShareWhiz InsightsGenerateGet startedCreate a free account to read the full story.Sign UpAlready have an account? Log inForgot password?